For the first time the clinical effect of acetazolamide (AZA) in haemorrhagic glaucoma has been the subject of a controlled study. The clinical impression of none, or a slight effect of AZA in haemorrhagic glaucoma was confirmed. An intravenous injection of AZA, 10 mg/kg body weight, produced in 13 patients (14 eyes) with haemorrhagic glaucoma a fall in the intraocular pressure (lOP) of only 7.7% within 30 min. A similar examination of 4 patients (5 eyes) with other types of glaucoma showed a drop in pressure of 32.0%. Examinations of the haemorrhagic-glaucoma eyes later that day and on the next day showed no further effect of AZA on the IOP. It is concluded that AZA is of no importance in the treatment of haemorrhagic glaucoma.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.